Structure-based Comparative Analysis and Prediction of N-linked Glycosylation Sites in Evolutionarily Distant Eukaryotes  by Lam, Phuc Vinh Nguyen et al.
Genomics Proteomics Bioinformatics 11 (2013) 96–104Genomics Proteomics Bioinformatics
www.elsevier.com/locate/gpb
www.sciencedirect.comORIGINAL RESEARCHStructure-based Comparative Analysis and Prediction
of N-linked Glycosylation Sites in Evolutionarily
Distant EukaryotesPhuc Vinh Nguyen Lam 1,3, Radoslav Goldman 2, Konstantinos Karagiannis 3,
Tejas Narsule 3, Vahan Simonyan 4, Valerii Soika 4, Raja Mazumder 3,*1 Life Sciences Department, Paris Diderot University, Paris 75013, France
2 Department of Oncology, Georgetown University, Washington, DC 20057, USA
3 Department of Biochemistry and Molecular Biology, George Washington University Medical Center, Washington, DC 20037, USA
4 Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USAReceived 17 September 2012; revised 2 November 2012; accepted 12 November 2012
Available online 28 February 2013*
C
16
by
htKEYWORDS
N-linked glycosylation;
Gain and loss of glycosyla-
tion;
nsSNP;
nsSNV;
VariationCorresponding author.
E-mail: mazumder@gwu.ed
Peer review under responsib
hinese Academy of Sciences a
Production an
72-0229/$ - see front matter ª
Elsevier B.V. All rights reserv
tp://dx.doi.org/10.1016/j.gpb.20u (Mazu
ility of B
nd Gene
d hostin
2013 Bei
ed.
12.11.003Abstract The asparagine-X-serine/threonine (NXS/T) motif, where X is any amino acid except
proline, is the consensus motif for N-linked glycosylation. Signiﬁcant numbers of high-resolution
crystal structures of glycosylated proteins allow us to carry out structural analysis of the N-linked
glycosylation sites (NGS). Our analysis shows that there is enough structural information from
diverse glycoproteins to allow the development of rules which can be used to predict NGS. A
Python-based tool was developed to investigate asparagines implicated in N-glycosylation in ﬁve
species: Homo sapiens, Mus musculus, Drosophila melanogaster, Arabidopsis thaliana and Saccharo-
myces cerevisiae. Our analysis shows that 78% of all asparagines of NXS/T motif involved in N-gly-
cosylation are localized in the loop/turn conformation in the human proteome. Similar distribution
was revealed for all the other species examined. Comparative analysis of the occurrence of NXS/T
motifs not known to be glycosylated and their reverse sequence (S/TXN) shows a similar distribu-
tion across the secondary structural elements, indicating that the NXS/T motif in itself is not bio-
logically relevant. Based on our analysis, we have deﬁned rules to determine NGS. Using machine
learning methods based on these rules we can predict with 93% accuracy if a particular site will be
glycosylated. If structural information is not available the tool uses structural prediction results
resulting in 74% accuracy. The tool was used to identify glycosylation sites in 108 human proteins
with structures and 2247 proteins without structures that have acquired NXS/T site/s due tomder R).
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Lam PVN et al / N-linked Glycosylation Sites 97non-synonymous variation. The tool, Structure Feature Analysis Tool (SFAT), is freely available to
the public at http://hive.biochemistry.gwu.edu/tools/sfat.Introduction
Co- and post-translational modiﬁcations (PTMs) modify the
function of proteins by the addition of speciﬁc chemical groups
that affect their thermodynamic, kinetic and structural proper-
ties. Glycosylation, one of the many types of PTMs, contrib-
utes to the diversiﬁcation of proteins by the addition of
structurally-diverse oligosaccharides. This modiﬁcation is
widespread and involved in a wide variety of biochemical
and cellular processes including protein folding, maintenance
of cell structure, receptor-ligand interaction, cell signaling
and cell-cell recognition [1–3]. The function of glycosylation
in health and disease attracts signiﬁcant attention with recent
reports on the effects of non-synonymous variations on glyco-
sylation [4], study of glycosylation in cellular pathophysiology
[5], pharmacological signiﬁcance of glycosylation in therapeu-
tic proteins [6], the signiﬁcance of glycosylation in the develop-
ment of biopharmaceuticals [7] and carbohydrate-based
vaccines [8].
N-linked glycosylation (NGS) occurs as a post-transla-
tional modiﬁcation and a co-translational process through
which carbohydrates (glycans) are added to an asparagine
(N) at the consensus motif asparagine-X-serine/threonine
(NXS/T) in which X is any amino acid except proline [9].
There are reports of other NGS motifs such as asparagine-
X-cysteine (NXC), but their frequency of occurrence is extre-
mely low [10,11]. The attachment of the glycan is assisted by
a hydrogen bond between the b-amide of asparagine as the
hydrogen bond donor and the oxygen of threonine (serine)
[12]. This process is catalyzed by the enzymatic action of N-
glycosyltransferases which attach glycan to the unfolded pro-
tein during protein synthesis [1]. It has been suggested that
NGS may contribute to the correct folding of proteins; exper-
imental evidence shows that interactions between the sugars
and the amino acids in the native state stabilizes the folding
of glycoproteins [13]. It has been concluded that the primary
structure of the NXS/T tri-peptide is necessary, but not sufﬁ-
cient, for glycosylation [10]. The most probable explanation
for this observation is that in addition to other factors such
as the localization of the protein, the adoption of an appropri-
ate conformation and solvent accessibility of this tri-peptide is
required for the glycosylation reaction [14,15].
Studies by Beeley [16] and later by Bause et al. [17] demon-
strated a statistical probability for glycosylated asparagine res-
idues to be located within a turn/loop conformation.
Availability of complete genomes, sensitive mass spectrometric
tools, and bioinformatic methods has resulted in recent conﬁr-
mation of these ﬁndings in many eukaryotes [10,11]. The
authors show that eukaryotic N-glycoproteins have invariant
sequence recognition patterns, structural constraints and sub-
cellular localization. Their analysis suggests that a large num-
ber of N-glycoproteins evolved after the split between fungi,
plants and animals to support organismal development, body
growth and organ formation speciﬁc to the corresponding
clade [11]. It has been shown by Park and Zhang [18] in a
comparative genomic study involving higher eukaryotes that
the glycosylated asparagines evolve more slowly than thenon-glycosylated counterparts in the same set of proteins.
The authors conclude that the solvent-accessible asparagines
are most likely to be glycosylated and of biological importance
[18]. A continued improvement of rule-based ﬁlters that pre-
dict occupancy of the large number of N-glycosylation sequons
is therefore important.
In this study, we performed a comprehensive structural
analysis of potential N-linked glycosylation sites in Homo sapi-
ens (human), Mus musculus (mouse), Saccharomyces cerevisiae
(yeast), Drosophila melanogaster (ﬂy) and Arabidopsis thaliana
(plant) to reﬁne the structural constrains of N-glycosylation
with the aim to formulate basic rules improving prediction
accuracy. We then used these rules to predict N-glycosylation
of NXS/T sequons created in the human genome by non-syn-
onymous single nucleotide variation (nsSNV). These rules
were incorporated into an N-linked glycosylation prediction
tool: Sequence Structure Feature Analysis Tool (SFAT). Our
analysis shows that current structural information is sufﬁcient
to develop such rules that are applicable to the entire prote-
ome. Such analyses can be used to prioritize targets for further
validation in the laboratory.Results and discussion
Structural analysis of annotated and unannotated NXS/T motif
The occurrence of the N-linked glycosylation sequence motif is
not sufﬁcient to determine if a particular site will get glycosyl-
ated. To better understand and describe the sequence and
structural parameters that allow a speciﬁc site to be glycosyl-
ated, and to see if these can be applied across evolutionarily
distant organisms, we have performed a comprehensive analy-
sis of the ﬁve following eukaryotic proteomes: human, mouse,
ﬂy, plant and yeast. Table 1 provides details of the data sets
used in this study.
Distribution of protein secondary structure elements in
eukaryotes
To understand the distribution of NGSs (annotated in Uni-
ProtKB/Swiss/Prot) and unannotated NXS/T motifs, we have
determined the distribution ofa-helix, b-sheet and loop/turn ele-
ments in all the non-redundant protein structures. The percent-
age of amino acids in these structural elements was calculated
for individual proteins and the percentage of a-helix, b-sheet
and loop/turn conformations for the all the proteins with struc-
tureswas then calculated. The results show that the distributions
of the three structural elements in all ﬁve species are very similar
with a-helix being the highest and b-Sheet the lowest secondary
structure conformation (Figure 1A). More speciﬁcally, the fre-
quency of a-helix, b-sheet and loop/turn conformation varies
in the organisms studied, which is 3847%, 2128% and
3133%, respectively. If asparagine is distributed evenly among
all secondary structure elements, then one should expect to ob-
serve similar frequencies of occurrences of the amino acid in the
three secondary structure elements. But this is not true as can be
seen from the next analysis results.
Table 1 Structure datasets used in this study
Organism Available structuresa No. of
annotated
NXS/T sites
No. of
unannotated
NXS/T sites
No. of
N sites
Total
length
Sheet
total length
Helix total length Loop/turn total length
Human 3094 2284 3779 30,762 1,627,531 377,793 713,587 536,151
Mouse 644 453 739 5984 91,718 31,568 24,182 35,968
Fly 103 42 103 1029 37,216 12,622 16,435 37,216
Plant 179 33 223 1834 136,158 30,062 62,978 43,118
Yeast 756 10 1163 16,745 191,581 41,428 87,412 62,741
Note: aStructures that have at least one asparagine in their sequence.
A
A
sp
ar
ag
in
e d
ist
ri
bu
tio
n 
(%
)
B
D
ist
ri
bu
tio
n 
of
 se
co
nd
ar
y 
st
ru
ct
ur
e 
(%
)
P < 0.0001
0
10
20
30
40
50
60
70
80
90
100
Human Mouse Fly Plant Yeast
α-Helix
β-Sheet
Loop/turn
0
10
20
30
40
50
60
70
80
90
100
Human Mouse Fly Plant Yeast 
α-Helix
β-Sheet
Loop/turn
Figure 1 The distribution of secondary structure elements and asparagine
A. Distribution of secondary structural elements in proteins of human, mouse, ﬂy, plant and yeast. B. Distribution of asparagine in
secondary structural elements in proteins of human, mouse, ﬂy, plant and yeast proteins. P values are calculated with v2 test by comparing
the occurrence of asparagine in secondary structural elements to the overall distribution of a-helix, b-sheet and turns/loops in all available
structures in the species of interest.
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It has been shown that NGS are more prevalent in turns
[14,16]. This observation would not have functional implica-
tions if the abundance of asparagines (N) in turns is similar
to the abundance of NGS sites in turns. There are 30,762 N-
containing sites in 3094 proteins with crystallographic PDB
structures for the human proteome; 5984 sites in 644 proteins
for mouse, 1029 sites in 103 proteins for ﬂy; 1834 sites in 179
proteins for plant and 16,745 sites in 756 proteins for yeast.
Figure 1B shows that asparagines are located preferentially
in the loop/turn conformation with a frequency of 4450%.
Compared to the results shown in Figure 1A, the percentage
of asparagines found in a-helix appears to be close to the ex-
pected (40.20% vs. 42.10%). However, the percentage of
asparagines is higher in turns/loops and lower in b-sheets than
expected. These results prompted us to examine whether the
distribution of potential NGS (annotated in UniProtKB/
Swiss/Prot) and unannotated NXS/T sites follows the same
pattern.
Distribution of unannotated NXS/T motif in protein secondary
structure elements
All UniProtKB/Swiss-Prot records are manually curated. Even
the prediction results of every protein are manually checked
before they are entered into the database. Therefore, annota-tions available from UniProtKB records are considered ‘gold
standard’ in terms of functional annotation. It is expected that
unannotated NXS/T motifs not known to carry a glycan (and
therefore functionally comparable to any N), should reﬂect the
overall distribution of asparagines. If we consider proteins
with crystallographic structures, there are 3779 unannotated
NXS/T motifs in human proteins, 739 sites for mouse, 1163
sites for yeast, 103 sites for ﬂy and 223 sites for plant. Accord-
ing to Figure 2A, the percentage of asparagines in the unanno-
tated NXS/T motif is slightly higher than that of all
asparagines (Figure 1B) in a turn conformation. It is possible
that this is a function of the tripeptide property. We therefore
wanted to see if the distribution of annotated NXS/T motifs is
signiﬁcantly different than that of the unannotated NXS/T
motifs.
Distribution of annotated NXS/T motif in protein secondary
structure elements
There are 2284 annotated NXS/T sites in 592 proteins which
have PDB structures in the human dataset. Among these,
1779 sites are in turn (78%), 222 sites in the a-helix (9.7%)
and 283 sites in the b-sheet (12.3%) (Figure 2B). This distribu-
tion, based on analysis of the entire set of available structures,
is consistent with recent results in the mouse showing 75% of
NGSs in turns and 15% in b-sheets [10]. The same tendency is
observed in our analysis for mouse, ﬂy, plant and yeast. In all
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Figure 2 The distribution of asparagine in unannotated and annotated NXS/T motifs
A. Distribution of unannotated NXS/T motifs in secondary structural elements. P values are calculated with v2 test by comparing the
occurrence of asparagine in unannotated NXS/T motif to the distribution of all asparagines. B. Distribution of annotated NXS/T motifs
in secondary structural elements. P values are calculated with v2 test by comparing the occurrence of asparagine in annotated NXS/T
motif to the distribution of asparagines in unannotated NXS/T motifs.
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Figure 3 Distribution of asparagines in human and mouse proteins
A. Distribution of asparagines in human proteins. B. Distribution of asparagines in mouse proteins.
Lam PVN et al / N-linked Glycosylation Sites 99the species the percentages of asparagine that are part of the
annotated motif is higher in loops/turns. The distribution of
annotated NXS/T sites is signiﬁcantly different from the distri-
bution of the unannotated NXS/T in all the species. Represen-
tative data were shown for human and mouse in Figure 3
(P< 0.0001).
Our results in mouse show a noticeable difference of the
distribution of NXS/T sites in loops/turns (60% for annotated
and 51% for unannotated), compared to the analysis of Zie-
linska et al. (75% and 71%, respectively) [10]. This is poten-
tially due to the fact that we have analyzed a larger set of
structures. The occurrence of Asn-sequons in this type of sec-
ondary structure is favored for three reasons: (i) loops/turns
represent spatial arrangements of the peptide chain which fa-
vor the hydrogen-bonded contact between the beta-amide of
asparagines and the hydroxyl group of carbohydrates; (ii)
turns constitute privileged conformations which guarantee
accessibility of the sugar-acceptor sites due to their general
location at the surface of proteins and (iii) these sites could
be evolutionary selected because of functional importance.Quantiﬁcation and functional analysis of N-glycosylation sites in
human and mouse proteome
UniProtKB contains 15,828 sites for the entire human prote-
ome where the sequon NXS/T is annotated as the N-linked
glycosylation site. Among them, 15,168 sites are found in ‘‘se-
creted and membrane proteins’’ and 747 sites in ‘‘cytoplasm
and nucleus proteins’’ (there are cases where the same protein
can be found in two different places). Thus, when comparing
annotated NXS/T motifs found in the human proteome,
approximately 96% of sites were found in ‘‘secreted and mem-
brane proteins’’ and only 4.7% sites in ‘‘cytoplasm, nucleus
proteins.’’ For mouse, 95% of the proteins with annotated
NXS/T motifs are ‘‘secreted and membrane proteins’’, while
only 3.8% are ‘‘cytoplasm and nucleus’’ proteins (in this case
some proteins do not have location information). In large-scale
analysis of NGS sites, it was found that none of the identiﬁed
glycoproteins are located in the mitochondria, cytosol or
nucleus [11]. Kung et al. [19] had identiﬁed mitochondrial
glycoproteins using protein microarrays and it is possible that
100 Genomics Proteomics Bioinformatics 11 (2013) 96–104they are either errors in the curated data or mitochondrial gly-
coproteins could not be captured because of the experimental
protocols used. It is also possible that some proteins could be
present in more than one compartment at different time points,
which might explain the differences in the results in Uni-
ProtKB and the aforementioned studies. Looking at the pro-
portion of NXS/T sites that are annotated and the total
number of NXS/T sites in the human proteome, the UniProt
data suggest that only 27% of all NXS/T sites are N-glycosyl-
ated. Among ‘‘secreted and membrane proteins’’, the number
increases to 53% of all NXS/T sites (Table 2). When compar-
ing annotated NXS/T motifs to total NXS/T motifs for mouse,
we ﬁnd 21% of NXS/T motifs is annotated, which is lower
than 27% for the human proteome, and this number increases
to 36% if only ‘‘secreted and membrane proteins’’ are
considered. This could be due to the fact that not all of mouse
proteome has been manually curated by UniProtKB/Swiss-
Prot curators and extreme caution is employed by Uni-
ProtKB/Swiss-Prot curators to ensure close to zero false posi-
tives. For cytoplasm/nucleus/mitochondria proteins, the
numbers are similar for human and mouse (Table 2).
These ﬁndings show that there exist a very high number of
NXS/T motifs in the proteome, but less than one third of them
have so far have been documented as glycosylated for both hu-
man and mouse. A higher percentage of annotated NXS/T
motifs are present in ‘‘secreted and membrane proteins’’ than
‘‘cytoplasm and nucleus proteins’’, which is consistent with
previously reported preferential N-glycosylation of proteins
in the secretory pathways [10]. Comparison of the NXS/T
and the reverse S/TXN site in the human proteome, which is
not expected to carry glycans, reveals 58,781 NXS/T sites
and 50,577 S/TXN sites (P= 0.9) (for additional details please
see Table S1). Similar distribution is observed in the mouse
proteome (data not shown). Additionally, for the human pro-
teome we noticed that there are 28,527 and 22,568 NXS/T sites
in secreted and membrane proteins and in cytoplasmic and nu-
clear proteins, respectively, which is signiﬁcantly different
(P < 0.0001). However, the number of the reverse motifs (S/
TXN) in secreted and membrane proteins and in cytoplasmic
and nuclear proteins is comparable, which is 21,213 and
21,375, respectively. It is important to note that similar results
were obtained in terms of the relative cellular distribution of
NXS/T and S/TXN sites, if only the proteins with PDB struc-
tural information were considered (Table S1), which strongly
supports the inclusion of just protein sequences with structural
information for the type of analysis performed in this study.
Non-synonymous single nucleotide variation and polymorphic
glycoproteins
The structural analysis shows that NGS are over-represented
on the surface of proteins. We ﬁnd that 91% of the annotated
sites in humans and 93% in mouse are solvent-accessible,
compared to 67% and 70% of the unannotated sites. We usedTable 2 Subcellular distribution of annotated NXS/T motifs in human
Species Entire proteome (%) Secreted/m
Human 27 53
Mouse 21 36
Note: Percentage of annotated NXS/T motifs against all NXS/T motifs ininformatic tools to extract information on polymorphic N-gly-
cosylation variants from the UniProtKB/Swiss-Prot database
and dbSNP [20]. Previously we have shown using pathway
and function enrichment analysis that a signiﬁcant number
of proteins that gain or lose the glycosylation motif are in-
volved in kinase activity, immune response and blood coagula-
tion [4]. However, it remains to be investigated whether a
polymorphic site can indeed be glycosylated when there is gain
of the NGS motif. Our current analysis shows that of the
20,238 proteins in the complete human proteome (based on
UniProtKB/Swiss-Prot), 3328 proteins contain polymorphic
sites that create or abolish existing glycosylation sites (Fig-
ure 4). We employed machine learning techniques based on
the rules developed from this study to examine the proteins
that have crystallographic structure information available at
NGS. As a result, we identiﬁed 108 out of 221 polymorphic
proteins with structures (Table S2), which have one or more
gain of glycosylation that are expected to have some impact
on protein function. Based on UniProtKB/Swiss-Prot and
Gene Ontology (GO) analysis, several of these proteins are in-
volved in blood coagulation, cell adhesion, host-pathogen
interaction, immunity and transport (Table S3). The major
molecular functions represented are hydrolases, receptors
and transferases. Out of 2299 proteins that do not have struc-
tures, 2247 proteins are predicted to be glycosylated at the gain
of glycosylation site by the SFAT tool (total NXS/T sites:
12,623; sites predicted as yes: 11,651 and sites predicted as
no: 972). Based on GO analysis using Panther tools [21], the
over-represented GO biological processes in this dataset in-
clude immune response, response to stimulus, signaling and
blood coagulation, which agrees with the our results obtained
previously [4].N-linked glycosylation prediction tool
The analysis that we have performed here represents an efﬁ-
cient way to explore the glycosylation potential of protein if
the structure is known. We have also extended the tool to work
on proteins without structure, albeit with lower accuracy: 74%
without structure compared to 93% with structure. It is ex-
pected that within the next decade, majority of proteins with
NGS will have their structures solved, or it will be possible
to generate high-quality homology models for these proteins
based on related protein structures. To provide easy compari-
son of these structures and sequences we have web-enabled our
tools developed for this study. The tool can perform the fol-
lowing tasks: (i) predict N-linked glycosylation sites, (ii) deter-
mine the secondary structural elements of any site of interest
(such as active site, metal binding site, N-linked glycosylation
site or any other sited based on user-deﬁned motif) and (iii)
map UniProtKB and PDB sequence features. The tool, Struc-
ture Feature Analysis Tool (SFAT), is expected to be useful forand mouse proteome
embrane (%) Cytoplasm/nucleus/mitochondria (%)
3
2.6
respective categories is shown.
20,238 human proteins
787,106 polymorphic sites
3328 N-linked glycosylation polymorphic proteins
1060 loss of N-linked glycosylation (LOG) sites
12,623 gain of N-linked glycosylation (GOG) sites
11,651 sites predicted by SFAT to be true GOG
Figure 4 Identiﬁcation of N-linked glycosylation (NLG) sites
using SFAT
Lam PVN et al / N-linked Glycosylation Sites 101researchers interested in site-speciﬁc quantitative structural
analysis. Figure 5 shows a snapshot of the SFAT interface.
Prediction of N-linked glycosylation sites
The prediction is performed using the following four basic
rules: (i) presence of Endoplasmic Reticulum targeting se-
quence; (ii) not nuclear, mitochondrial or cytoplasmic; (iii)
present in a loop or turn and (iv) exposed. Data for the ﬁrst
two rules are extracted from the UniProtKB ﬂat ﬁle. The third
piece of information is extracted from the PDB ﬁle and the rel-
ative solvent accessibility is obtained from Deﬁne Secondary
Structure of Proteins (DSSP) database [22]. When structure
is not available, the last two pieces of information is predicted.
We identiﬁed 96 new (currently not annotated in UniProt)
NGS in the human proteome that matches all four rules
(3.6% of the total unannotated NXS/T sites). Instead of using
a set of strict rules for prediction which can potentially lead to
large numbers of false negatives, we implemented these rules
into a machine learning framework for better prediction accu-
racy. Using this approach our cross validation prediction mod-
el showed the overall accuracy of 93%, and the precision for
true positive of 90% for proteins with structures. The accuracyFigure 5 Home page for N-linked glycosylation prediction tool SFAT
User can either predict N-linked glycosylation sites, ﬁnd the distributio
and PDB sequence features.and precision is 74% and 70%, respectively, when the tool is
applied to proteins without structures. The model was then
used to predict NGS in the polymorphic glycoproteins. The re-
sults showed that for the gain of N-glycosylation, around 40%
are predicted to be glycosylated.
There are several other NGS prediction tools currently
available. However, none of them use a rule-based method
that is dependent on structural information. EnsembleGly
[23], a sequence-based method using ensembles of support vec-
tor machine classiﬁers, has 94% accuracy; NetNGlyc (http://
www.cbs.dtu.dk/services/NetNGlyc/) uses artiﬁcial neural net-
works that examine the sequence context of Asn-X-Ser/Thr
sequons with an overall accuracy of 76%. In addition, GPP
[24] uses the random forest algorithm and pairwise patterns
to predict glycosylation sites with an accuracy of 90.8% for
Ser sites, 92.0% for Thr sites and 92.8% for Asn sites. It is
important to note here that the authors used their own training
and test datasets to determine the accuracy of their tools. A di-
rect comparison between different tools is thus difﬁcult be-
cause the tools were developed and tested on different
training and test datasets. Furthermore, the deﬁnition of neg-
ative NGS is an open discussion, because it is difﬁcult to prove
deﬁnitively that a particular residue is not glycosylated under
any conditions, although experiments can verify that a partic-
ular residue can be glycosylated.
Determining the secondary structure elements of any amino acid
site
Knowledge of the distribution of a speciﬁc motif in the second-
ary structure elements can be useful to predict the functional
relevance. To facilitate studies similar to the one described
here, we implement within SFAT an option that can provide
a distribution report of any motif of interest. The input ﬁle
is the UniProtKB ﬂat ﬁle. The tool gives the user multiple op-
tions about different feature information in UniProtKB such
as: N-linked glycosylation, active site or metal-binding site.
Alternatively, the user can deﬁne their motif of interest.
Instructions for how to determine the correct pattern can be
found in the Help document. The results are given in a down-
loadable table. A pie chart and plot graph are generated to
illustrate the obtained results.
Mapping of UniProtKB and PDB features
Sequences from PDB and UniProt may not be identical (PDB
sequences can be shorter or longer compared to then of a motif in secondary structural elements or map UniProtKB
102 Genomics Proteomics Bioinformatics 11 (2013) 96–104UniProtKB sequence). Therefore, it is important to align them
to explore the different feature annotations that are available
on the sequence from UniProt or PDB. Often this task is done
manually and can lead to errors. We have implemented a sim-
ple alignment tool and the features are extracted from Uni-
ProtKB ﬂat ﬁles and PDB records and the user can easily
identify the features of interest in the amino acid sequence.
This tool was used in this study to further analyze the poly-
morphic glycosylation sites.Conclusion
Comparative structural study of asparagines in human, mouse,
ﬂy, plant and yeast showed that a high percentage of aspara-
gines in NXS/T motifs implicated in N-glycosylation are local-
ized within a turn/loop and are solvent-exposed at the protein
surface. The N-glycosylated proteins are typically not
cytoplasmic, nuclear or mitochondrial. We have incorporated
these observations into an N-glycosylation prediction tool
which combines structure- and sequence-based rules that sig-
niﬁcantly improve sequence-based prediction methods. The
tool was used to predict glycosylation sites of a set of polymor-
phic human proteins.Materials and methods
By ‘annotated’ glycosylation sites, we mean NXS/T sites that
are indicated as the N-linked glycosylation site in Uni-
ProtKB/Swiss-Prot [25] protein record, while unannotated gly-
cosylation sites include all other NXS/T sites. We consider
these annotated glycosylation sites as potential NGS, as they
have been manually curated by UniProtKB/Swiss-Prot cura-
tors based on experimental evidence, similarity to experimen-
tally-validated NGS in homologous proteins and/or in-depth
sequence and functional analysis. UniProtKB/Swiss-Prot hu-
man proteome is considered the gold standard set of manu-
ally-curated human proteins and in our opinion provides the
best positive and negative datasets, since UniProtKB/Swiss-
Prot curators have manually curated all entries for the human
proteome. All predictions are checked manually by curators to
ascertain if there are any homologous sites in related proteins.
Predictions that are dubious are not included in the sequence
feature annotation.Datasets
All data were collected from UniProtKB and Protein Data
Bank (PDB) [26]. For the human proteome, the complete pro-
teome available from UniProtKB/Swiss-Prot was used. For
mouse, the ﬁle rp-seqs-15.fasta.gz from http://pir.george-
town.edu/rps/data/current/15/ was downloaded and parsed
to obtain the complete proteome. This was done because the
complete proteome of mouse from UniProtKB has several po-
tential splice variants as separate entries. All other proteomes
were obtained from UniProtKB using the ‘complete proteome’
keyword tag. The access dates for all data retrievals are be-
tween 15th February and 15th June, 2012. Experimentally-val-
idated datasets were obtained from UniProtKB and
supplementary materials in Zielinska et al. [10,11].Data analysis
Python scripts were used to extract information from Uni-
ProtKB ﬂat ﬁle feature (FT) lines, cross-reference (DR) lines
for PDB database and sequence (SQ) lines. Information was
also extracted from the PDB ﬁles in order to get secondary
structure information. For annotated N-linked glycosylation
sites, all UniProt FT lines annotated as ‘‘N-linked’’ whether
‘‘conﬁrmed’’, ‘‘potential’’ or ‘‘by similarity’’ were retained.
The positions of these sites were retrieved and the correspond-
ing sequences were checked for the NXS/T motif. PDB IDs
were extracted from UniProtKB ﬂat ﬁles. As there can be more
than one PDB ﬁle mapped to any UniProtKB protein, the
PDB structure which meets the following criteria was selected:
the structure was determined by x-ray diffraction, highest res-
olution, and the site of interest is contained within the solved
structure. Once selected, PDB ﬁles were downloaded from
PDB and the positions aligned to the PDB sequence and the
secondary structure was determined based on the secondary
structure assignment in the PDB ﬁle.
Relative solvent accessibility was calculated using the infor-
mation in DSSP database [22]. Based on the value of the rela-
tive accessible surface area (ASA), the residues were grouped
as buried (0.0–0.25) or exposed (0.25–1.0). The choice of the
threshold was based on previous studies [10,18,27]. For ma-
chine learning using classiﬁcation and regression tree (CART),
we allow CART to automatically select the relative ASA based
on the test set. MUSCLE was used to perform pairwise align-
ment to map UniProtKB protein sequences to PDB [28]. Pre-
diction of the N-terminal targeting sequences was performed
using Predotar [29]. Subcellular location analysis is performed
based on UniProtKB keywords. For sequences that do not
have structural information, secondary structure and surface
accessibility of the individual amino acid was predicted using
NetSurfp [30]. P value was calculated using a binomial statistic
based on methodology described earlier [31,32]. P value of 0.05
or less was considered signiﬁcant.
Identiﬁcation of polymorphic glycosylation sites
Gain of glycosylation sites were identiﬁed by using variation
data from UniProtKB FT lines and dbSNP [20,33]. Entries
were ﬁrst mapped to UniProtKB accessions using the ID map-
ping service [34] followed by sequence mapping. This resulted
in a table with UniProtKB accession numbers and position of
variation, the variation and the data source (Table S2).
Machine learning using CART
This method consists of creating a model that predicts the va-
lue or a class for a predictive variable based on several input
variables. The algorithms of this decision tree usually work
top-down by choosing a variable at each step that is the next
best variable to use in splitting the set of items. ‘‘Best’’ is de-
ﬁned by how well the variable splits the set into homogeneous
subsets that have the same value of the predictive variable [35].
As the number of unannotated sites is higher than that of the
annotated sites in our analysis of the human proteome (2:3 ra-
tio), the training dataset for our prediction model contains 200
experimentally-validated sites (noted as positive) and 300
unannotated sites (noted as negative). Training classiﬁers are
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unbalanced with more negative sites than positive sites, which
can result in poor classiﬁcation of the minority class (in this
case positive sites). One solution is to change the distribution
of major and minor classes during training by randomly select-
ing a subset of the training data. However, this approach does
not then take into consideration all available information in
the real dataset. Therefore, we chose our training dataset to
contain original data in a ratio that reﬂects the natural dataset.
First, a set of patterns is generated from the training data
for each of the glycosylation sites and then used to generate
a value for each instance. Multiple runs are performed with
each instance collecting weights to determine the positive or
negative NGS class. Each of the runs used dataset comprising
randomly chosen positive and negative instances from the
cross validation fold. The accuracy of the prediction was eval-
uated by cross validation (described below).
The variables that describe the dataset are selected based on the
rules derived from this study: (i) ER targeting sequence (ii) sub-cel-
lular location, (iii) secondary structure and (iv) exposed/buried. To
build the classiﬁcationmodel, the function ‘rpart’ in statistical lan-
guage R was used. Twenty-fold internal cross validation was per-
formed to validate the training dataset as described previously
[24]. More speciﬁcally, the dataset was partitioned randomly into
20 sections and the training procedure was carried out using 19
of these while the 20th section provides a test dataset. This was re-
peated20 timesoneachoccasionwithadifferent sectionof thedata
acting as the test set. The evaluation of the model is based on the
number of true positives (TP), false positives (FP), true negatives
(TN), false negatives (FN). The model was then used to predict
NGS in the test dataset.
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